A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 284, 171-178
Abstract
No abstract availableKeywords
Funding Information
- University of North Carolina (DMS-1517274, DMS-1412844, DMS-1462992, DMS-1664645, 2013-39274, R35 GM119661, R01 HL141934)
- National Science Foundation (DMS-1517274, DMS-1412844, DMS-1462992, DMS-1664645, 2013-39274, R35 GM119661, R01 HL141934)
- David and Lucile Packard Foundation (DMS-1517274, DMS-1412844, DMS-1462992, DMS-1664645, 2013-39274, R35 GM119661, R01 HL141934)
- National Institutes of Health (DMS-1517274, DMS-1412844, DMS-1462992, DMS-1664645, 2013-39274, R35 GM119661, R01 HL141934)
This publication has 57 references indexed in Scilit:
- Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPKCPT: Pharmacometrics & Systems Pharmacology, 2015
- Anti‐PEGimmunity: emergence, characteristics, and unaddressed questionsWIREs Nanomedicine and Nanobiotechnology, 2015
- Review on modeling anti-antibody responses to monoclonal antibodiesJournal of Pharmacokinetics and Pharmacodynamics, 2014
- Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodiesJournal of Pharmacokinetics and Pharmacodynamics, 2013
- Applications of minimal physiologically-based pharmacokinetic modelsJournal of Pharmacokinetics and Pharmacodynamics, 2012
- Membrane attack by complement: the assembly and biology of terminal complement complexesImmunologic Research, 2011
- Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisitedBiopharmaceutics & Drug Disposition, 2010
- Antibody against poly(ethylene glycol) adversely affects PEG‐asparaginase therapy in acute lymphoblastic leukemia patientsCancer, 2007
- Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular DeliveryPharmaceutical Research, 2007
- Optimization and Upscaling of Doxorubicin-Containing Liposomes for Clinical UseJournal of Pharmaceutical Sciences, 1990